Tecan unveils Cavro Magni Flex OEM robotic liquid handling instrument development platform

Tecan unveiled its new Cavro® Magni Flex OEM robotic liquid handling instrument development platform at this year’s AACC Annual Scientific Meeting & Clinical Lab Expo. This modular and scalable solution is intended for low to medium throughput workflows, offering the flexibility and functionality to quickly and easily create innovative automation systems for virtually any life sciences application, from immunoassay processing to molecular diagnostics.

Tecan unveils Cavro Magni Flex OEM robotic liquid handling instrument development platform
The  Cavro Magni Flex simplifies liquid handling automation

The Cavro Magni Flex provides the core robotic architecture for the development of complete automation solutions, with a highly configurable workdeck designed to accommodate a wide range of labware formats and devices to meet specific workflow requirements. A variety of carriers, cutouts and custom grids are available to create any number of layouts, and the system is available with a choice of two, four or eight independent pipetting channels. The platform’s liquid handling arm offers variable tip spacing capabilities – to suit different labware types and enable reformatting activities – and can act as both a pipettor and gripper, optimizing use of the available space.

The Cavro Magni Flex takes advantage of the exceptional quality and robustness of the Tecan Cavro range of OEM liquid handling components to provide a comprehensive, modular liquid handling framework that allows seamless integration into any system. Supplied with Tecan’s MAPlinx™ development software kit – which includes high level functional commands for straightforward programming, a worktable editor with virtual library and drag-and-drop features, and a 3D simulator to simplify software testing – the Cavro Magni Flex aims to accelerate instrument development and time to market.

Joe Rotter, Vice President, Global Marketing for Life Science Components at Tecan, commented:

The Cavro Magni Flex is designed to stay ahead of the ever changing needs of our partners and the evolving market. It offers advanced software development capabilities and exceptional design flexibility to provide easy access to liquid handling automation for faster instrument development. In the future, it will enable customers to monitor their install base remotely, for superior performance monitoring and implementation of productivity enhancements.”

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Tecan. (2019, December 06). Tecan unveils Cavro Magni Flex OEM robotic liquid handling instrument development platform. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/news/20191206/Tecan-unveils-Cavro-Magni-Flex-OEM-robotic-liquid-handling-instrument-development-platform.aspx.

  • MLA

    Tecan. "Tecan unveils Cavro Magni Flex OEM robotic liquid handling instrument development platform". News-Medical. 31 October 2024. <https://www.news-medical.net/news/20191206/Tecan-unveils-Cavro-Magni-Flex-OEM-robotic-liquid-handling-instrument-development-platform.aspx>.

  • Chicago

    Tecan. "Tecan unveils Cavro Magni Flex OEM robotic liquid handling instrument development platform". News-Medical. https://www.news-medical.net/news/20191206/Tecan-unveils-Cavro-Magni-Flex-OEM-robotic-liquid-handling-instrument-development-platform.aspx. (accessed October 31, 2024).

  • Harvard

    Tecan. 2019. Tecan unveils Cavro Magni Flex OEM robotic liquid handling instrument development platform. News-Medical, viewed 31 October 2024, https://www.news-medical.net/news/20191206/Tecan-unveils-Cavro-Magni-Flex-OEM-robotic-liquid-handling-instrument-development-platform.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tecan and Oxford Nanopore build alliance to create automated, seamless and fully compatible nanopore sequencing library preparation for any-length fragments of native DNA/RNA